Prevalence of airway obstruction assessed by lung function questionnaire

Mayo Clinic Proceedings

Volumn 86, Issue 5, 2011, Pages 375-381

  Mintz, Matthew L ^a   Yawn, Barbara P ^b   Mannino, David M ^c   Donohue, James F ^d   Hanania, Nicola A ^e   Grellet, Catherine A ^f   Gilsenan, Alicia W ^g   McLeod, Lori D ^g   Dalal, Anand A ^h   Raphiou, Ibrahim H ^h   Prillaman, Barbara A ^h   Crater, Glenn D ^h   Cicale, Michael J ^h   Mapel, Douglas W ⁱ  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b OLMSTED MEDICAL CENTER   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f About Women's Health Medical Group   (United States)

^g RTI HEALTH SOLUTIONS   (United States)

^h GLAXOSMITHKLINE   (United States)

ⁱ LOVELACE CLINIC FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SALBUTAMOL;

ACCURACY; ADULT; AGE; ARTICLE; CASE FINDING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION QUESTIONNAIRE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PREVALENCE; QUESTIONNAIRE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SPIROMETRY;

EID: 79955647054     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/mcp.2010.0787     Document Type: Article

References (24)

1. Miniño AM, Xu J, Kochanek KD. Deaths: preliminary data for 2008. Nat Vital Stat Rep. 2010;59(2):1-70. http://www.cdc.gov/nchs/data/nvsr/nvsr59/ nvsr59-02.pdf Accessed February 18, 2011.
2. Centers for Disease Control and Prevention (CDC). Deaths from chronic obstructive pulmonary disease-United States, 2000-2005. MMWR Morb Mortal Wkly Rep. 2008;57(45):1229-1232.
3. Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest. 2002;121(5, suppl):121S-126S.
4. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveill Summ. 2002;51(6):1-16.
5. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2000;160(11):1683-1689.
6. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am J Med. 2003;114(9):758-762. (Pubitemid 36776358)
7. Coultas DB, Mapel D, Gagnon R, Lydick E. The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med. 2001;164(3):372-377. (Pubitemid 32778201)
8. 1: the Lung Health Study. JAMA. 1994;272(19):1497-1505. http://www.ncbi.nlm.nih.gov/sites/entrez?cmd= Retrieve&db=PubMed&lis t-uids=7966841&dopt=Abstract.
9. Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med. 2002;166(5):675-679. (Pubitemid 34971849)
10. Murray RP, Connett JE, Rand CS, Pan W, Anthonisen NR. Persistence of the effect of the Lung Health Study (LHS) smoking intervention over eleven years. Prev Med. 2002;35(4):314-319. (Pubitemid 35365396)
11. Anthonisen NR, Skeans MA, Wise RA, et al. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med. 2005;142(4):233-239. (Pubitemid 40216240)
12. Anthonisen NR, Woodlrage K, Manfreda J. Use of spirometry and respiratory drugs in Manitobans over 35 years of age with obstructive lung diseases. Can Respir J. 2005;12(2):69-74. (Pubitemid 40561750)
13. US Preventive Services Task Force. Screening for chronic obstructive pulmonary disease using spirometry: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;148(7):529-534.
14. Ohar JA, Sadeghnejad A, Meyers DA, Donohue JF, Bleecker ER. Do symptoms predict COPD in smokers? Chest. 2010;137(6):1345-1353.
15. Lin K, Watkins B, Johnson T, Rodriguez JA, Barton MB. Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;148(7):535-543. (Pubitemid 351665424)
16. Qaseem A, Snow V, Shekelle P, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2007;147(9):633-638. (Pubitemid 351664484)
17. Global initiative for chronic Obstructive Lung Disease. Global Strategy for Diagnosis, Management, and Prevention of COPD. 2009. http://www.goldcopd. com/guidelineitem.asp?l1=2&l2=1&intID=2003. Accessed February 18, 2011.
18. Yawn BP, Mapel DW, Mannino DM, et al. Development of the Lung Function Questionnaire (LFQ) to identify airflow obstruction. Int J Chron Obstruct Pulmon Dis. 2010;5:1-10.
19. Fabbri L, Pauwels RA, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD Executive Summary updated 2003. COPD. 2004;1(1):105-141.
20. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319-338. (Pubitemid 41079078)
21. Begg CB, Greenes RA. Assessment of diagnostic tests when disease verification is subject to selection bias. Biometrics. 1983;39(1):207-215.
22. Hanania NA, Mannino DM, Yawn BP, et al. Predicting risk of airflow obstruction in primary care: validation of the lung function questionnaire (LFQ). Respir Med. 2010;104(8):1160-1170.
23. Wilt TJ, Niewoehner D, Kim C, et al. Use of spirometry for case finding, diagnosis, and management of chronic obstructive pulmonary disease (COPD). Evid Rep Technol Assess (Summ). 2005;(121):1-7.
24. National Lung Health Education Program. http://www.nlhep.org/. Accessed Feburary 18, 2011.